🔴 Ocugen is trading 5.3% down today on normal volatility despite a rising biotech sector

Ocugen is trading 5.3% down at $1.26 today on normal volatility, as there are no fresh company-specific headlines or trial updates to drive the move.

• The decline occurs despite a broadly stronger market and gains across the wider biotech sector.
• Without a clear catalyst like earnings or clinical results, the move reflects standard price action for a low-priced biotech name.